Barba-Pichardo Rafael, Moriña-Vázquez Pablo, Venegas-Gamero José, Maroto-Monserrat Fernando, Cid-Cumplido Manuela, Herrera-Carranza Manuel
Unidad de Arritmias y Marcapasos, Servicio de Cuidados Críticos y Urgencias, Hospital Juan Ramón Jiménez, A. Sundheim 30, 21003 Huelva, Spain.
Rev Esp Cardiol. 2006 Jun;59(6):553-8.
Permanent His-bundle pacing is effective in patients with supra-Hisian atrioventricular block. We report our experience in patients with infra-Hisian atrioventricular block.
The study involved selected patients referred for syncope and intraventricular conduction disturbance, infra-Hisian atrioventricular block, with left ventricular dyssynchrony and no coronary sinus access. All patients underwent electrophysiological study to evaluate infra-Hisian atrioventricular conduction, both at baseline and after flecainide administration. We selected patients with an indication for permanent pacing in whom His-bundle pacing produced a narrow QRS complex. Leads were implanted in the right atrium, in the bundle of His, and at the apex of the right ventricle, and connected to the atrial, left ventricular, and right ventricular terminals, respectively, of a biventricular pacemaker generator. All pacemakers were programmed in DDD mode with a left ventricle-right ventricle interval of 80 ms.
Between February and December 2004, seven patients met the study's inclusion criteria. The His-bundle lead was implanted successfully in five. The His-bundle pacing threshold remained stable in two patients, whereas it increased in three. During follow-up, at between 2 and 12 months, no lead dislodgement or failure to capture was observed. Echocardiography did not disclose any deterioration in ventricular function, or any worsening of or new valvular incompetence, but showed that ventricular dyssynchrony had disappeared in previously affected patients.
His-bundle pacing is the only pacing mode capable of inducing a physiologically normal ventricular contraction. It can be used in some patients with infra-Hisian atrioventricular block.
永久性希氏束起搏对希氏束以上房室传导阻滞患者有效。我们报告了我们在希氏束以下房室传导阻滞患者中的经验。
该研究纳入了因晕厥和室内传导障碍、希氏束以下房室传导阻滞、左心室不同步且无冠状窦通路而转诊的特定患者。所有患者均接受电生理研究,以评估基线时和服用氟卡尼后希氏束以下的房室传导情况。我们选择了有永久性起搏指征且希氏束起搏能产生窄QRS波群的患者。电极分别植入右心房、希氏束和右心室心尖,并分别连接到双心室起搏器发生器的心房、左心室和右心室端。所有起搏器均程控为DDD模式,左心室-右心室间期为80毫秒。
2004年2月至12月期间,7例患者符合研究纳入标准。5例成功植入希氏束电极。2例患者的希氏束起搏阈值保持稳定,3例升高。随访期间,在2至12个月时,未观察到电极脱位或夺获失败。超声心动图未显示心室功能恶化,也未发现瓣膜关闭不全加重或出现新的瓣膜关闭不全,但显示先前受累患者的心室不同步已消失。
希氏束起搏是唯一能够诱发生理性正常心室收缩的起搏模式。它可用于一些希氏束以下房室传导阻滞的患者。